A STUDY COMPARING THE EFFECTS OF EPOETIN HOSPIRA AND EPOGEN/EPOETIN ALFA (AMGEN) WHEN ADMINISTERED IV IN PATIENTS WITH CHRONIC RENAL FAILURE REQUIRING HEMODIALYSIS AND RECEIVING EPOETIN MAINTENANCE TREATMENT: